You are here

liver cancer

AstraZeneca’s Imfinzi and Imjudo found to extend survival in liver cancer trial

Clinical Trials Arena

Tue, 09/17/24 - 10:52 am

clinical trials

ESMO: Despite checkered past, Merck's Keytruda-Lenvima pairing looks to change practice in liver cancer subtype

Fierce Pharma

Sun, 09/15/24 - 06:30 pm

BMS eyes April FDA verdict on Opdivo/Yervoy in liver cancer

Pharmaphorum

Thu, 08/22/24 - 11:09 am

Bristol Myers Squibb

Elevar, Hengrui eye quick refile for PD-1 liver cancer combo after surprise FDA rejection

Fierce Pharma

Wed, 07/10/24 - 11:06 am

Elevar Therapeutics

Jiangsu Hengrui Pharmaceuticals

Coherus, Junshi’s PD-1 blocker Loqtorzi aces phase III liver cancer trial

BioSpace

Thu, 06/13/24 - 11:23 am

Coherus Biosciences

Junshi Biosciences

ASCO: With Opdivo-Yervoy combo, Bristol Myers calls Roche and AstraZeneca's bets in first-line liver cancer

Fierce Pharma

Tue, 06/4/24 - 11:52 am

Bristol Myers Squibb

HLB fails to win US FDA's approval for Rivoceranib liver cancer drug

Korea Times

Sun, 05/19/24 - 10:39 pm

Geneos cancer vaccine shrinks liver tumors in small trial

Reuters

Sun, 04/7/24 - 04:40 pm

clinical trials

BMS racks up phase III win in liver cancer targeted by AstraZeneca and Roche

BioSpace

Wed, 03/20/24 - 11:51 am

Bristol Myers Squibb

immuno-oncology

AstraZeneca charts new course for Imfinzi in liver cancer, but FDA path remains uncertain

Fierce Pharma

Fri, 01/19/24 - 11:13 am

Medivir partners with world-leading liver cancer experts in new Scientific Advisory Council

BioSpace

Mon, 08/7/23 - 10:48 am

AstraZeneca’s liver cancer treatment shows ‘continued survival benefit’ in phase 3 trial

Biopharma Reporter

Mon, 07/3/23 - 10:46 am

clinical trials

Genentech reveals positive results from cancer combo therapy trial

Clinical Trials Arena

Mon, 04/17/23 - 11:24 am

hepatocellular carcinoma

AACR: Patient deaths taint Roche's industry-first early-stage liver cancer readout for Tecentriq and Avastin

Fierce Pharma

Sun, 04/16/23 - 11:26 pm

Roche’s Tecentriq to be filed for early-stage liver cancer

Pharmaphorum

Thu, 01/19/23 - 09:41 am

clinical trials

J&J leads $85M investment in HistoSonics ahead of liver cancer device authorization

Medtech Dive

Wed, 12/14/22 - 10:41 am

venture capital

AstraZeneca gets first okay for CTLA4 drug tremelimumab

Pharmaphorum

Mon, 10/24/22 - 10:50 am

$2.4B BridgeBio/Helsinn Liver Cancer Deal Falls Apart

BioSpace

Thu, 10/13/22 - 11:53 pm

ESMO 2022 – the new liver cancer entrants line up

EP Vantage

Thu, 09/8/22 - 10:39 am

Pages